LONG-TERM RESULTS OF NASOPHARYNGEAL CARCINOMA TREATMENT (BASED ON THE ANALYSIS OF CASES FROM CANCER REGISTRY OF N.N. BLOKHIN RUSSIAN CANCER RESEARCH CENTER DURING 1980–2010)

T. D. Tabolinovskaya; Таболиновская Т. Д.; A. M. Mudunov; Мудунов А. М.; R. I. Azizyan; Азизян Р. И.; I. N. Pustynskiy; Пустынский И. Н.; T. A. Aketova; Акетова Т. А.

doi:10.17650/2222-1468-2016-6-4-15-18

LONG-TERM RESULTS OF NASOPHARYNGEAL CARCINOMA TREATMENT (BASED ON THE ANALYSIS OF CASES FROM CANCER REGISTRY OF N.N. BLOKHIN RUSSIAN CANCER RESEARCH CENTER DURING 1980–2010)

Authors: Tabolinovskaya T.D.¹, Mudunov A.M.¹, Azizyan R.I.¹, Pustynskiy I.N.¹, Aketova T.A.¹
Affiliations:
1. N.N. Blokhin Russian Cancer Research Center
Issue: Vol 6, No 4 (2016)
Pages: 15-18
Section: DIAGNOSIS AND TREATMENT OF HEAD AND NECK TUMORS
Published: 08.12.2016
URL: https://ogsh.abvpress.ru/jour/article/view/245
DOI: https://doi.org/10.17650/2222-1468-2016-6-4-15-18
ID: 245

Cite item

Full Text

Abstract
About the authors
References
Supplementary files
Statistics

Abstract

Data on 573 patients with nasopharyngeal carcinoma registered for treatment in N.N. Blokhin Russian Cancer Research Center in 1980–2010 was used for the analysis. The study revealed high rate of late-stage diagnosis of nasopharyngeal carcinoma (82.9 %), low cancer suspicion, poor diagnostics in general practice (73.2 %). Active screening for nasopharyngeal carcinoma is virtually absent in Russia. According to the study results, combined radiotherapy is an optimal method for nasopharyngeal cancer treatment; chemoradiotherapy with platinum drugs, doxorubicin, bleomycin combined with hyperfractionated radiotherapy is preferable for treatment of locally advanced and reginal tumors.